Use wechat scan QR code < / P > < p > to share with friends and circle of friends < / P > < p > <-- Startfragment -- > < / P > < p > Financial Association, May 7, for < a target = "_ blank" href=" https://news.163.com/news/search?keyword=%E7%BE%8E%E5%9B%BD "> U.S. < / a > government recently proposed to abandon < a target ="_ blank" href=" https://news.163.com/news/search?keyword=%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97 "> the appeal for the patent of new crown vaccine < / a > has aroused doubts and opposition from all walks of life in Germany. On May 6 local time, a German government spokesman said the US plan would bring "serious trouble" to vaccine production. If there is no profit incentive from R & D, then pharmaceutical manufacturers may not develop and manufacture vaccines in the future, according to the company. A spokesman for the German government said the factors limiting the production of the new vaccine were production capacity and high quality standards, not patents. She stressed that intellectual property protection is the source of innovation（ Related reading: < / b > < p > < p > < b > What's the calculation of the United States changing its support to give up the new crown vaccine patent

京ICP备19009350号-2